TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IKT

Inhibikase Therapeutics Inc

Healthcare · Biotechnology

2.10$ -2.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow IKT
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.02 -0.07 0.54 -0.20 -0.67 -4.71 -4.13 -3.39 -0.81 -0.28
– – – – – 0.00 0.00 0.03 0.00 0.00
0.24 0.17 0.48 0.84 0.34 0.50 0.11 0.09 0.34 0.16
0.24 0.20 1.01 1.26 1.30 0.74 – – – –
0.15 -0.02 1.13 0.95 -0.28 -0.58 0.04 0.04 0.01 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00 0.00
0.07 0.05 0.07 – – – -3.81 2.19 -1.56 0.02
– – – – – 0.03 – – – –
– – – – – -0.03 – – – –
-0.02 0.08 -0.02 -0.01 0.16 -0.01 -0.06 0.00 – –
-0.02 0.08 -0.33 -0.01 8.99 13.54 -0.05 1.58 4.36 1.10
-0.04 0.00 0.27 -0.21 8.32 8.83 -7.99 0.37 2.00 0.84
-0.02 -0.07 0.54 -0.20 -0.67 -4.71 -4.19 -3.39 -0.81 -0.28

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?